[What is new in the genetics of type 2 diabetes].
Polychronakos
Constantin
C
D000818:Animals; D027682:Cation Transport Proteins / Q000235:genetics; D002879:Chromosomes, Human, Pair 10 / Q000235:genetics; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics; D015198:Designer Drugs; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D015894:Genome, Human; D018398:Homeodomain Proteins / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007231:Infant, Newborn; D007339:Insulysin / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D015997:Neonatal Screening; D020641:Polymorphism, Single Nucleotide; D014157:Transcription Factors / Q000172:deficiency / Q000235:genetics; D000075703:Zinc Transporter 8
D027682:Cation Transport Proteins; D015198:Designer Drugs; D005819:Genetic Markers; C078492:HHEX protein, human; C513080:Hhex protein, mouse; D018398:Homeodomain Proteins; D007004:Hypoglycemic Agents; C492522:SLC30A8 protein, human; D014157:Transcription Factors; D000075703:Zinc Transporter 8; D007339:Insulysin